Podcast Review: Science Weekly – Why British women are freezing their eggs abroad

The Science Weekly podcast's recent exploration of egg freezing abroad offers a compelling glimpse into a phenomenon that sits at the intersection of reproductive autonomy, economic inequality, and globalised healthcare. Through the personal account of Guardian journalist Lucy Hough, who travelled to Brussels for egg freezing treatment, the programme illuminates both the promise and the pitfalls of what might be termed 'speculative fertility tourism'.

Hough's story begins with a familiar narrative: the breakdown of a relationship she had expected would lead to motherhood, leaving her at 34 grappling with mounting anxieties about her reproductive future. Her description of dating with the biological clock ticking, giving off what she candidly calls 'deranged energy', will be familiar to many and reflects the deep psychological toll of time-pressured fertility decisions. What's particularly encouraging is that Hough appeared well-informed about the realities of egg freezing from the outset. She understood that 35 represents a crucial threshold for fertility preservation and that multiple cycles would likely be necessary to bank sufficient eggs. This suggests that educational messaging about optimal timing and realistic expectations is finally breaking through to potential users, a significant development given the field's history of overpromising outcomes.

However, Hough's experience also exposes the stark economic barriers within the UK system. Facing costs of £8,000-9,000 per cycle, she encountered what she describes as 'bougie' London clinics where she felt pressured into additional treatments and services. This boutique approach to fertility care, where egg freezing is packaged as luxury self-care rather than 'simply' a medical treatment, mirrors trends which first emerged in the American reproductive medicine scene. Seeking alternatives, Hough underwent the procedure in Brussels, where the total cost (including ten years of storage) came to roughly one-third of UK prices (€2,500 plus medication costs).

While research specifically examining cross border travel for social egg freezing remains limited, the broader phenomenon of fertility tourism is well-documented. Traditional motivations for crossing borders for fertility treatment include legal, ethical or regulatory restrictions in one's home country, treatment availability or access issues, desire for anonymity (in the case of gamete donation) and of course issues of cost and funding.

However, the UK has one of the most permissive regulatory climates since the law change in 2022 which permit frozen eggs to be stored for up to 55 years (see BioNews 1111), and to be used in treatment with sperm donation or with a reproductive partner till a woman is in her late 40s and potentially beyond. Therefore, what makes Hough's journey distinctive is its singular focus on economics rather than the complex regulatory or ethical constraints that typically drive reproductive travel.

This, I suggest, positions cross-border egg freezing closer to conventional medical tourism, such as dental work in Hungary or bariatric surgery in Turkey, where cost differentials are the primary driver. Research on medical tourism identifies familiar motivations: availability, affordability, perceived quality, and practical familiarity. Furthermore, studies show that patients often return to places where they've previously lived or worked, with it being particularly common among diaspora communities to return 'home' for treatment. Hough's experience aligns with this pattern. Her choice of Brussels wasn't arbitrary, she had existing connections and familiarity with the location (she lived and worked there), providing practical advantages like language capabilities, local knowledge, and emotional support networks.

In our post-COVID remote working environment, the ability to work from anywhere makes such arrangements increasingly feasible, eliminating the need for extended leave or expensive intermediary services. Nonetheless, the emergence of companies offering curated 'egg freezing retreats' and group fertility trips, complete with Instagram-worthy luxury experiences, represents a fascinating evolution in reproductive tourism. Yet Hough's honest account of feeling too unwell from ovarian stimulation to engage in sightseeing provides a sobering counterpoint to these carefully marketed packages.

But why are these cost differentials so dramatic? Perhaps answer lies in part in structural differences between healthcare systems. Countries like Belgium and Denmark benefit from state-subsidised or non-profit fertility centres that keep private sector prices competitive, while nations such as Spain and the Czech Republic actively court fertility tourists through favourable tax policies and competitive pricing. By contrast the UK's fragmented, largely profit-driven market offers little price standardisation, creating an environment where costs remain unpredictably high, compounded by the prevalence of expensive 'add-on' treatments (see BioNews 1283). As Professor Joyce Harper noted in the podcast, patients often face pressure to purchase unproven additional services, a practice that exploits vulnerability and hope.

Following her treatment, Hough describes the experience as simultaneously empowering and anxiety-relieving. Yet significant questions remain unaddressed. Will she undergo additional cycles? How will she navigate the complexities of using her eggs internationally or arranging costly and risky transportation to the UK, a process made more complicated by Brexit bureaucracy? Perhaps most critically, Hough doesn't mention Belgium's ten-year storage limit, meaning she must either use her eggs or arrange their transfer within this timeframe.

Travelling overseas for egg freezing, particularly to familiar locations, offers undeniable appeal, but potential patients must carefully consider storage restrictions, usage limitations, and the logistical complexities of international egg transport. However, research suggests that only around ten percent of people who freeze their eggs ultimately return to use them. This raises a provocative question about the future landscape of cross-border travel for egg freezing. Might we eventually face a cohort of abandoned eggs scattered across European clinics, left in suspended animation by owners who moved on with their lives, started families naturally, or simply changed their minds?

If cross-border egg freezing becomes more common, we may need to consider not just the immediate benefits for individual patients like Hough, but the longer-term implications of a reproductive system that encourages people to scatter their genetic material across international borders. Unlike traditional cross-border fertility treatment, where patients travel with the immediate intention of achieving pregnancy, egg freezing represents a fundamentally different proposition: the preservation of possibility. In most cases, these eggs will never be called upon, making this a uniquely speculative form of fertility tourism where genetic material is distributed internationally on the basis of anxiety and hope rather than concrete family-building plans.